Lawsuit notice: investors who hold regeneron pharmaceuticals, inc. (nasdaq: regn) shares should contact the shareholders foundation

San diego, march 24, 2025 (globe newswire) -- shareholders foundation, inc. announced that a lawsuit is pending for certain investors in shares of regeneron pharmaceuticals, inc. (nasdaq: regn). investors who purchased shares of regeneron pharmaceuticals, inc. (nasdaq: regn) prior to november 2023 and continue to hold any of those nasdaq: regn shares, should contact the shareholders foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
REGN Ratings Summary
REGN Quant Ranking